Development of Receptor Binding Domain (RBD)‐Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS‐CoV‐2 Delta and Other Variants
Abstract
Research context
OpenAlex topics: SARS-CoV-2 and COVID-19 Research · SARS-CoV-2 detection and testing · COVID-19 Clinical Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Human Virology Key Laboratory of Tropical Disease Control of Ministry Education Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology Zhongshan School of Medicine Sun Yat‐sen University Guangzhou Guangdong 510080 China
Center for Infection and Immunity Study School of Medicine Shenzhen Campus of Sun Yat‐sen University Shenzhen Guangdong 518107 China
Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences Guangzhou Guangdong 510080 China
Qianyang Biomedical Research Institute Guangzhou Guangdong 510063 China
Department of Gastroenterology The Eight Affiliated Hospital Sun Yat‐sen University Shenzhen Guangdong 518033 China
Guangzhou National Laboratory Bio‐Island Guangzhou Guangdong 510320 China
BSL‐3 Laboratory Zhongshan School of Medicine Sun Yat‐sen University Guangzhou Guangdong 510080 China
Guangdong Provincial Center for Disease Control and Prevention Guangzhou 511430 China
Department of Immunology Zhongshan School of Medicine Sun Yat‐sen University Guangzhou 510080 China
Center for Precision Medicine Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences Guangzhou 510080 China
Funding
National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities · Pearl River S and T Nova Program of Guangzhou